Metraipolis › archive › dc_08a0cf186ea2

Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42713005
DOI
10.1002/exp2.70223
License (as archived)
solo-consultazione
Archived
2026-10-15T21:58:57.635Z
SHA-256 of the archived text
f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d
Stable URL of this page
https://metraipolis.com/documento/dc_08a0cf186ea2

How to cite

Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005 — Europe PMC (en), https://europepmc.org/article/MED/42713005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08a0cf186ea2 (Metraipolis archive dc_08a0cf186ea2, sha256 f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d)
BibTeX
@misc{dc08a0cf186ea2,
  title = {Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42713005},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08a0cf186ea2; sha256 f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42713005. Agents can read the archived copy with the MCP tool read_document.